Qiang Lin Selected Research

Vascular purpura

11/2015

Characterization of the binding of shikonin to human immunoglobulin using scanning electron microscope, molecular modeling and multi-spectroscopic methods.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiang Lin Research Topics

Disease

24	Neoplasms (Cancer) 11/2022 - 03/2003
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 12/2009
14	Infections 01/2022 - 04/2016
7	Osteoarthritis 10/2021 - 01/2013
6	Stroke (Strokes) 01/2022 - 01/2015
6	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2013
4	Pain (Aches) 01/2022 - 09/2007
3	Knee Osteoarthritis 01/2022 - 01/2019
3	Fibrosis (Cirrhosis) 01/2022 - 02/2019
3	Virus Diseases (Viral Diseases) 09/2021 - 11/2016
3	HIV Infections (HIV Infection) 07/2021 - 01/2011
3	Glioma (Gliomas) 01/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 06/2018 - 05/2014
3	Lung Neoplasms (Lung Cancer) 11/2016 - 10/2013
3	Inflammation (Inflammations) 10/2016 - 01/2010
3	Esophageal Neoplasms (Esophageal Cancer) 10/2015 - 02/2008
2	Body Weight (Weight, Body) 05/2022 - 11/2020
2	Bacterial Infections (Bacterial Infection) 05/2022 - 11/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 10/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 09/2019
2	Oculocutaneous albinism type 2 01/2020 - 01/2016
2	Osteoporosis 01/2019 - 05/2014
2	Coinfection 10/2017 - 09/2016
2	Carcinoma (Carcinomatosis) 04/2017 - 07/2010
2	Purpura 01/2017 - 05/2012
2	Carcinogenesis 09/2016 - 01/2012
2	Esophagitis 04/2016 - 02/2008
1	Thyroid Neoplasms (Thyroid Cancer) 06/2022
1	Unstable Angina 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Congenital Abnormalities (Deformity) 12/2021

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2010
6	Messenger RNA (mRNA)IBA 01/2022 - 06/2012
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2009
5	Biological ProductsIBA 04/2021 - 05/2014
5	Therapeutic UsesIBA 01/2017 - 03/2005
4	MicroRNAs (MicroRNA)IBA 07/2020 - 07/2016
4	RNA (Ribonucleic Acid)IBA 03/2020 - 08/2015
4	Carboplatin (JM8)FDA LinkGeneric 08/2013 - 07/2011
4	Vinorelbine (Navelbine)FDA LinkGeneric 08/2013 - 07/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020 - 07/2010
3	Antiviral Agents (Antivirals)IBA 07/2020 - 04/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2014
3	Glucose (Dextrose)FDA LinkGeneric 09/2019 - 11/2016
3	Pharmaceutical PreparationsIBA 01/2019 - 10/2016
3	Peptide Hydrolases (Proteases)FDA Link 06/2018 - 06/2016
3	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2015 - 05/2014
3	IntegrinsIBA 11/2015 - 07/2014
3	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 02/2008
3	Fluorouracil (Carac)FDA LinkGeneric 01/2015 - 02/2008
2	p38 Mitogen-Activated Protein KinasesIBA 05/2022 - 06/2015
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2015
2	HirudinsIBA 01/2022 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2010
2	Complementary DNA (cDNA)IBA 01/2021 - 05/2004
2	InterferonsIBA 07/2020 - 07/2016
2	Melanins (Melanin)IBA 01/2020 - 01/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2019 - 10/2016
2	LipidsIBA 09/2019 - 07/2015
2	Glutamine (L-Glutamine)FDA Link 09/2019 - 01/2017
2	Alanine Transaminase (SGPT)IBA 02/2019 - 05/2004
2	Temozolomide (Temodar)FDA LinkGeneric 11/2018 - 01/2018
2	Combined VaccinesIBA 10/2017 - 09/2016
2	CarbonIBA 03/2017 - 11/2016
2	Complement System Proteins (Complement)IBA 01/2017 - 05/2012
2	Mitogen-Activated Protein KinasesIBA 11/2015 - 01/2013
2	Matrix Metalloproteinase 13IBA 11/2015 - 01/2013
2	Docetaxel (Taxotere)FDA Link 01/2015 - 04/2012
1	Carbon DioxideIBA 05/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2022
1	MAP Kinase Kinase 6IBA 05/2022
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2022
1	GlutaminaseIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	NAD (NADH)IBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Thrombin FDA Link 01/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	Glutamate DehydrogenaseIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2022
1	PAR-1 ReceptorIBA 01/2022
1	AlbuminsIBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 12/2021

Therapy/Procedure

13	Therapeutics 11/2022 - 03/2003
10	Radiotherapy 02/2020 - 02/2008
8	Drug Therapy (Chemotherapy) 04/2016 - 07/2011
4	Chemoradiotherapy 10/2020 - 02/2008
3	Conformal Radiotherapy 08/2013 - 07/2011
3	Acupuncture Therapy 08/2011 - 03/2005
2	Lymph Node Excision (Lymph Node Dissection) 06/2022 - 08/2015
2	Art Therapy 07/2021 - 01/2021
2	Highly Active Antiretroviral Therapy (HAART) 08/2017 - 01/2011
2	Length of Stay 10/2015 - 07/2015
1	Cardiac Rehabilitation 01/2022
1	Tai Ji (Tai Chi Chuan) 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Neurological Rehabilitation 01/2022
1	Microbubbles 10/2021